Allergy Shots Boost Quality of Life for Young Patients, Three-Year Study Shows

A new study confirms that pollen allergen immunotherapy—commonly known as allergy shots—significantly improves quality of life in children and adolescents over a three-year period. For healthcare systems and insurers, the findings suggest the treatment delivers sustained benefits that could reduce long-term care costs and school absences.

Originaltitel: Treatment with pollen allergen immunotherapy improves health-related quality of life in children and adolescents: a three-year follow-up-study